ATYR 8-K 2026-11-06

aTYR PHARMA INC (ATYR) 8-K dated 2026-11-06 — accession 0001339970-26-000085.

aTYR PHARMA INC (ATYR) is a biotechnology company listed on US.

aTYR PHARMA INC filed a 8-K on 2026-11-06. Accession 0001339970-26-000085.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ATYR revenue for 2025-12-31 was $190.0K. Net income was -$74.1M. Revenue was down 19.1% from 2024-12-31 to 2025-12-31. ATYR currently screens at market cap $471.7M.

Not investment advice. The ATYR SEC hub lists recent forms. The stock page is the research view.